Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

<p><strong>Background</strong></p> Doxycycline is often used for treating COVID-19 respiratory symptoms in the community despite an absence of evidence from clinical trials to support its use. We aimed to assess the efficacy of doxycycline to treat suspected COVID-19 in the c...

Podrobná bibliografie
Hlavní autoři:	Butler, CC, Yu, L-M, Dorward, J, Gbinigie, O, Hayward, G, Saville, BR, Van Hecke, O, Berry, N, Detry, MA, Saunders, C, Fitzgerald, M, Harris, V, Djukanovic, R, Gadola, S, Kirkpatrick, J, Ogburn, E, Patel, MG, de Lusignan, S, Evans, PH, Thomas, NPB, Hobbs, FDR
Další autoři:	PRINCIPLE Trial Collaborative Group
Médium:	Journal article
Jazyk:	English
Vydáno:	Elsevier 2021

Podobné jednotky

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Autor: PRINCIPLE Trial Collaborative Group, a další
Vydáno: (2021)

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Autor: Yu, L-M, a další
Vydáno: (2021)

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Autor: Yu, L-M, a další
Vydáno: (2021)

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Autor: PRINCIPLE Trial Collaborative Group, a další
Vydáno: (2021)

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Autor: Dorward, J, a další
Vydáno: (2022)

Inhaled budesonide for COVID-19 in people at higher risk of complications in the community: the UK National Community Randomi
Autor: Gbinigie, O, a další
Vydáno: (2023)

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
Autor: Hayward, G, a další
Vydáno: (2021)

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Autor: Hayward, G, a další
Vydáno: (2024)

High-dose budesonide for early COVID-19 - Authors' reply
Autor: Hobbs, FDR, a další
Vydáno: (2021)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship
Autor: de Lusignan, S, a další
Vydáno: (2021)

The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: A rapid review
Autor: Dorward, J, a další
Vydáno: (2021)

Inclusion and diversity in the PRINCIPLE trial
Autor: Patel, MG, a další
Vydáno: (2021)

Suspected Doxycycline Induced Acute Interstitial Nephritis
Autor: Andrew Abrahamian, a další
Vydáno: (2023-05-01)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study.
Autor: de Lusignan, S, a další
Vydáno: (2021)

Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU).
Autor: Raja Dhar, a další
Vydáno: (2023-01-01)

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Autor: Butler, CC, a další
Vydáno: (2022)

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): preliminary analysis from the united kingdom randomised, controlled open-label, platform adaptive trial
Autor: Butler, C, a další
Vydáno: (2022)

A targeted approach to vaccine hesitancy
Autor: Leston, M, a další
Vydáno: (2023)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study
Autor: Simon de Lusignan, a další
Vydáno: (2021-10-01)

Penetration of doxycycline in aqueous humour
Autor: Kulshrestha O, a další
Vydáno: (1981-01-01)

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
Autor: Sarah Tonkin-Crine, a další
Vydáno: (2021-06-01)

Excess mortality from COVID-19 in an English sentinel network population
Autor: Joy, M, a další
Vydáno: (2020)

Doxycycline prophylaxis in malaria.
Autor: Gilks, C, a další
Vydáno: (1987)

Doxycycline induced Esophagitis
Autor: Banu Karakus Yilmaz, a další
Vydáno: (2014-02-01)

Comparison between Efficacy of Ciprofioxacin -Doxycycline with Rifampin – Doxycycline Regimens inrelapse of Brucellosis
Autor: Hossein Sarmadian, a další
Vydáno: (2014-08-01)

A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis.
Autor: Chaowagul, W, a další
Vydáno: (1999)

Transdermal Delivery System of Doxycycline-Loaded Niosomal Gels: Toward Enhancing Doxycycline Stability
Autor: Ahlam Zaid Alkilani, a další
Vydáno: (2024-07-01)

Effect of doxycycline and doxycycline with carica papaya on thrombocytopenia and leucopenia in acute dengue fever patients
Autor: Vivek Pambhar, a další
Vydáno: (2022-01-01)

Different Concentrations of Doxycycline in Swine Manure Affect the Microbiome and Degradation of Doxycycline Residue in Soil
Autor: Qiufan Yan, a další
Vydáno: (2018-12-01)

Treatment of Morgellons disease with doxycycline
Autor: Jeff F. Zhang, a další
Vydáno: (2021-12-01)

Actinic granuloma responding to doxycycline
Autor: George M. Jeha, BS, a další
Vydáno: (2020-11-01)

Doxycycline in the current clinical practice
Autor: Zyryanov S.K., a další
Vydáno: (2020-03-01)

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Autor: Gbinigie, O, a další
Vydáno: (2023)

Evaluation of the doxycycline release from AH26 sealer-doxycycline combination: An ex vivo study
Autor: Kazem Ashofteh Yazdi, a další
Vydáno: (2011-09-01)

Doxycycline promotes proteasome fitness in the central nervous system
Autor: Edmund Charles Jenkins, a další
Vydáno: (2021-08-01)

Experiences of urine collection devices during suspected Urinary Tract Infections: qualitative study
Autor: Glogowska, M, a další
Vydáno: (2023)

Doxycycline PEP can induce doxycycline resistance in Klebsiella pneumoniae in a Galleria mellonella model of PEP
Autor: Chris Kenyon, a další
Vydáno: (2023-08-01)

Scrub typhus and the misconception of doxycycline resistance
Autor: Wangrangsimakul, T, a další
Vydáno: (2019)

Doxycycline Degradation by the Oxidative Fenton Process
Autor: Alexandre A. Borghi, a další
Vydáno: (2015-01-01)

Use of doxycycline in modern clinical practice
Autor: R. S. Kozlov, a další
Vydáno: (2014-12-01)